Activation of the neuroprotective angiotensin-converting enzyme 2 in rat ischemic stroke

Hypertension

Volumn 66, Issue 1, 2015, Pages 141-148

  Bennion, Douglas M ^a   Haltigan, Emily A ^a   Irwin, Alexander J ^a   Donnangelo, Lauren L ^a   Regenhardt, Robert W ^a   Pioquinto, David J ^a   Purich, Daniel L ^a   Sumners, Colin ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

angiotensin converting enzyme 2; stroke

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; DIMINAZENE ACETURATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; MESSENGER RNA; MLN 4760; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; 2-(1-CARBOXY-2-(3-(3,5-DICHLOROBENZYL)-3H-IMIDAZOL-4-YL)ETHYLAMINO)-4-METHYLPENTANOIC ACID; 7-ALA-ANGIOTENSIN (1-7); ADAM PROTEIN; ANGIOTENSIN II; DIMINAZENE; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; IMIDAZOLE DERIVATIVE; LEUCINE; NEUROPROTECTIVE AGENT; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BLOOD; BRAIN CIRCULATION; CEREBRAL INFARCTION; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT;

ADAM PROTEINS; ANGIOTENSIN II; ANIMALS; CEREBRAL CORTEX; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CORPUS STRIATUM; DIMINAZENE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENZYME ACTIVATION; IMIDAZOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENTRICULAR; LEUCINE; MALE; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 84939221256     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05185     Document Type: Article

References (31)

1. Joo H, George MG, Fang J, Wang G., A literature review of indirect costs associated with stroke. J Stroke Cerebrovasc Dis 2014 23 1753 1763. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.017
2. Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C., Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol 2014 11 413 426. doi: 10.1038/nrcardio.2014.59
3. Greenberg DA., Preclinical stroke research: gains and gaps. Stroke 2013 44 6 suppl 1 S114 S115. doi: 10.1161/STROKEAHA.113.002088
4. Peña Silva RA, Heistad DD., Promising neuroprotective effects of the angiotensin-(1-7)-Angiotensin-converting enzyme 2-Mas axis in stroke. Exp Physiol 2014 99 342 343. doi: 10.1113/expphysiol.2013.076836
5. Mecca AP, Regenhardt RW, O'Connor TE, Joseph JP, Raizada MK, Katovich MJ, Sumners C., Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp Physiol 2011 96 1084 1096. doi: 10.1113/expphysiol.2011.058578
6. Jiang T, Gao L, Guo J, Lu J, Wang Y, Zhang Y., Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br J Pharmacol 2012 167 1520 1532. doi: 10.1111/j.1476-5381.2012.02105.x
7. Regenhardt RW, Desland F, Mecca AP, Pioquinto DJ, Afzal A, Mocco J, Sumners C., Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 2013 71 154 163. doi: 10.1016/j.neuropharm.2013.03.025
8. Chen J, Xiao X, Chen S, Zhang C, Chen J, Yi D, Shenoy V, Raizada MK, Zhao B, Chen Y., Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension 2013 61 681 689. doi: 10.1161/HYPERTENSIONAHA.111.00202
9. Chen J, Zhao Y, Chen S, Wang J, Xiao X, Ma X, Penchikala M, Xia H, Lazartigues E, Zhao B, Chen Y., Neuronal over-expression of ACE2 protects brain from ischemia-induced damage. Neuropharmacology 2014 79 550 558. doi: 10.1016/j.neuropharm.2014.01.004
10. Zheng JL, Li GZ, Chen SZ, Wang JJ, Olson JE, Xia HJ, Lazartigues E, Zhu YL, Chen YF., Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence. CNS Neurosci Ther 2014 20 452 459. doi: 10.1111/cns.12233
11. Jiang T, Yu JT, Zhu XC, Zhang QQ, Tan MS, Cao L, Wang HF, Lu J, Gao Q, Zhang YD, Tan L., Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway. Br J Pharmacol 2014 171 4222 4232. doi: 10.1111/bph.12770
12. Regenhardt RW, Mecca AP, Desland F, Ritucci-Chinni PF, Ludin JA, Greenstein D, Banuelos C, Bizon JL, Reinhard MK, Sumners C., Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats. Exp Physiol 2014 99 442 453. doi: 10.1113/expphysiol.2013.075242
13. Kulemina LV, Ostrov DA., Prediction of off-Target effects on angiotensin-converting enzyme 2. J Biomol Screen 2011 16 878 885. doi: 10.1177/1087057111413919
14. Lu J, Jiang T, Wu L, Gao L, Wang Y, Zhou F, Zhang S, Zhang Y., The expression of angiotensin-converting enzyme 2-Angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides 2013 47 289 295. doi: 10.1016/j.npep.2013.09.002
15. Chang AY, Li FC, Huang CW, Wu JC, Dai KY, Chen CH, Li SH, Su CH, Wu RW., Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke. Neurobiol Dis 2014 71 292 304. doi: 10.1016/j.nbd.2014.08.005
16. Regenhardt RW, Bennion DM, Sumners C., Cerebroprotective action of angiotensin peptides in stroke. Clin Sci (Lond) 2014 126 195 205. doi: 10.1042/CS20130324
17. Kuriakose S, Uzonna JE., Diminazene aceturate (Berenil), a new use for an old compound? Int Immunopharmacol 2014 21 342 345. doi: 10.1016/j.intimp.2014.05.027
18. Mogi M, Kawajiri M, Tsukuda K, Matsumoto S, Yamada T, Horiuchi M., Serum levels of renin-Angiotensin system components in acute stroke patients. Geriatr Gerontol Int 2014 14 793 798. doi: 10.1111/ggi.12167
19. Mo YJ, Huang WH, Chen DL, Chen FR., Relationship of angiotensin-converting enzyme 2 gene polymorphism with the prognosis of hypertensive stroke patients. Nan Fang Yi Ke Da Xue Xue Bao 2010 30 84 87
20. Haschke M, Schuster M, Poglitsch M, Loibner H, Salzberg M, Bruggisser M, Penninger J, Krähenbühl S., Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin Pharmacokinet 2013 52 783 792. doi: 10.1007/s40262-013-0072-7
21. Haber PK, Ye M, Wysocki J, Maier C, Haque SK, Batlle D., Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro. Hypertension 2014 63 774 782. doi: 10.1161/HYPERTENSIONAHA.113.02856
22. Qi Y, Zhang J, Cole-Jeffrey CT, Shenoy V, Espejo A, Hanna M, Song C, Pepine CJ, Katovich MJ, Raizada MK., Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension 2013 62 746 752. doi: 10.1161/HYPERTENSIONAHA.113.01337
23. Kagiyama T, Kagiyama S, Phillips MI., Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul Pept 2003 110 241 247
24. Sriramula S, Cardinale JP, Francis J., Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One 2013 8 e63847. doi: 10.1371/journal.pone.0063847
25. Xiao L, Haack KK, Zucker IH., Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-Activated protein kinase and extracellular signal-regulated kinase 1/2 signaling. Am J Physiol Cell Physiol 2013 304 C1073 C1079. doi: 10.1152/ajpcell.00364.2012
26. Xia H, Sriramula S, Chhabra KH, Lazartigues E., Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res 2013 113 1087 1096. doi: 10.1161/CIRCRESAHA.113.301811
27. Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ, Oudit GY., Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol 2014 66 167 176. doi: 10.1016/j.yjmcc.2013.11.017
28. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004 203 631 637. doi: 10.1002/path.1570
29. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, Kristosturyan E, Whitney AR, Sturdevant DE, Dorward DW, Holland SM, Kreiswirth BN, Musser JM, DeLeo FR., Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2010 2 560 575. doi: 10.1159/000317134
30. Robertshaw HJ, Brennan FM., Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro. Br J Anaesth 2005 94 222 228. doi: 10.1093/bja/aei021
31. Regueiro A, Cuadrado-Godia E, Bueno-Betí C, Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: Time-course after acute myocardial infarction and stroke. J Mol Cell Cardiol 2015 80 146 155. doi: 10.1016/j.yjmcc.2015.01.005.